Neurologic Outcomes in People With Multiple Sclerosis Treated With Immune Checkpoint Inhibitors for Oncologic Indications. Quinn CM, Rajarajan P, Gill AJ, Kopinsky H, et al. Neurology 2024;103:e210003.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Quinn CM, Rajarajan P, Gill AJ, Kopinsky H, et al. Neurologic Outcomes in People With Multiple Sclerosis Treated With Immune Checkpoint Inhibitors for Oncologic Indications. Neurology 2024;103:e210003.
PMID: 39541548